Sourav Kole

Sourav Kole has been a Member Board of Directors at NeuroTherapia, Inc., Libra Therapeutics, Cerevance, QurAlis, Therini Bio, Inc., and Paros Bio since 2022. In 2022, they also became a Director Board of Directors at MindImmune Therapeutics, Inc. and Reservoir Neuroscience. Sourav has been a Managing Director at Dolby Family Ventures since 2022, where they lead the Life Sciences practice focused on neuro investments. Since 2019, they have been a Strategic Partnerships at Verily Life Sciences (fka Google Life Sciences), where they have built and managed strategic partnerships and joint ventures as the business lead for a wide-range of next-generation technologies at the convergence of life sciences, data science, and tech. The financial value of partnerships that they have managed is $500M+.

Sourav Kole holds a Doctor of Philosophy (Ph.D.) in Biomedical Engineering from the University of Utah and a Bachelor of Science in Biomedical Engineering from Penn State University.